Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06541002 · ClinicalTrials.gov registry record · NA
A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors
A NA study of Sexual Dysfunction and Stem Cell Transplant Complications, sponsored by Massachusetts General Hospital.
- Recruiting
- Registry status
- NA
- Development phase
- 300
- Enrollment target
- 3
- Study locations
NCT06541002 is a NA study of Sexual Dysfunction and Stem Cell Transplant Complications that is actively recruiting participants, run by Massachusetts General Hospital. The registered enrollment target is 300 participants, below the 953-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (69% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06541002, a NA study of Sexual Dysfunction and Stem Cell Transplant Complications, is actively recruiting participants, sponsored by Massachusetts General Hospital.
- RECRUITING
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.
Conditions Studied
Interventions
- BEHAVIORAL SHIFT Intervention Group
- BEHAVIORAL Enhanced Usual Care Group
Study Locations (3)
Florida
- University of Miami - Coral Gables
Massachusetts
- Massachusetts General Hospital (MGH) - Boston
Pennsylvania
- Fox Chase Cancer Center - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-01-27 |
| Est. Completion | 2030-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06541002
The ClinicalTrials.gov registry entry for NCT06541002 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 953-participant average among 20 other Sexual Dysfunction trials with a reported enrollment target (69% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Sexual Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which SHIFT Intervention Group is the first listed.
NCT06541002 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Massachusetts, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06541002 about?
NCT06541002 is a clinical study titled "A Novel Digital Application (SHIFT) to Improve Outcomes for Hematopoietic Stem Cell Transplant Survivors". This research study is evaluating the efficacy of a novel self-administered digital application for improving sexual health outcomes, quality of life, and psychological distress in hematopoietic stem cell transplant survivors.
What is the current status of trial NCT06541002?
This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2025-01-27. Estimated completion is 2030-04-30.
What conditions does trial NCT06541002 study?
This clinical trial studies the following conditions: Sexual Dysfunction, Stem Cell Transplant Complications, Bone Marrow Transplant Complications.
What interventions are being tested in trial NCT06541002?
The interventions under investigation include: SHIFT Intervention Group (BEHAVIORAL), Enhanced Usual Care Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT06541002?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06541002 being conducted?
This trial has 3 study locations across Florida, Massachusetts, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sexual Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
RECRUITING · NA
-
BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women
RECRUITING · NA
-
Prostate Stimulation for Sexual Dysfunction
RECRUITING · NA
-
AYA OMGYES Sexual Health Study
RECRUITING · NA
-
Improving Women's Function After Pelvic Radiation
ACTIVE NOT RECRUITING · NA
-
Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.